The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Facilities
Facilities
Eli Lilly plans to invest $6B in new API manufacturing facility in Alabama
The Huntsville active pharmaceutical ingredient site will produce small molecule synthetic and peptide medicines, including Lilly's oral GLP-1 orforglipron.
Dec. 10, 2025
Facilities
Ardena’s US expansion positions the CDMO for growth amid geopolitical uncertainty
Dec. 9, 2025
Facilities
US pharma manufacturing investments reaching unprecedented levels: report
Dec. 1, 2025
Facilities
Agilent’s Biovectra CDMO business grows on the back of GLP-1 strength
Nov. 26, 2025
Facilities
Novartis to lay off 550 workers at Swiss plant amid investment in automation
Nov. 25, 2025
Facilities
AstraZeneca commits $2B to Maryland manufacturing expansion
Nov. 24, 2025
Facilities
Novartis plans to build manufacturing hub in North Carolina with $771M investment
Nov. 20, 2025
Facilities
Regeneron to invest $2B in a former magazine printing facility in New York
Nov. 19, 2025
Facilities
Integration of Lonza’s Vacaville biologics site, acquired from Roche in 2024, is progressing
Nov. 12, 2025
Looking for Something?
Load More Content
